Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|November 2, 1999
Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss familiesS Zeerleder, M Schloesser, M Redondo, et al.
Cancer Detection and Prevention|January 1, 1997
Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomasM Redondo, A Concha, F Ruiz-Cabello, et al.
Medicina|April 22, 2008
[Type I DNA topoisomerase from protozoan pathogens as a potential target for anti-tumoral drugs]Rosa M Reguera, Yolanda Pérez-Pertejo, Carmen M Redondo, et al.
Toxicon : Official Journal of the International Society on Toxinology|April 27, 2018
Overview of the role of Shiga toxins in porcine edema disease pathogenesisNatalia A Casanova, Leandro M Redondo, Gabriela C Dailoff, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2001
Quality assurance of point-of-care testing in the Costa del Sol Healthcare Area (Marbella, Spain)M L Hortas, N Montiel, M Redondo, et al.
Andrologia|October 31, 2001
Alterations in sperm protein phosphorylation in male infertilityM L Hortas, J A Castilla, M T Gil, et al.
Brain Research|January 11, 2001
Upregulation of glial clusterin in brains of patients with AIDsJ E Torres-Muñoz, M Redondo, C Czeisler, et al.
The Journal of Biological Chemistry|October 18, 1996
JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytesP Gómez del Arco, S Martínez-Martínez, V Calvo, et al.
Drug Discovery Today|July 19, 2006
Targeting atypical trypanosomatid DNA topoisomerase IRafael Balaña-Fouce, Carmen M Redondo, Yolanda Pérez-Pertejo, et al.
Cancer Research|September 15, 1991
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parametersM Redondo, A Concha, R Oldiviela, et al.
Pageof 22